SCYNEXIS Inc. | Key People and Executives

Marco Taglietti
President, Chief Executive Officer & Director
Guy MacDonald
Chairman
Marion McCourt
Independent Director
David C. Hastings
Independent Director
Clarence Patrick Machado
Independent Director
Ann F. Hanham
Independent Director
Steven C. Gilman
Independent Director
Marco Taglietti
President, Chief Executive Officer & Director
Eric Francois
Chief Financial Officer
David Angulo Gonzalez
Chief Medical Officer
Rajeshwar Motheram
Vice President-Pharmaceutical Development
Scott Sukenick
General Counsel
Guy MacDonald
Chairman
Marion McCourt
Independent Director
David C. Hastings
Independent Director
Clarence Patrick Machado
Independent Director
Ann F. Hanham
Independent Director
Steven C. Gilman
Independent Director

About SCYNEXIS

View Profile
Address
1 Evertrust Plaza
Jersey City New Jersey 07302
United States
Employees -
Website http://www.scynexis.com
Updated 07/08/2019
SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.